Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 28, 2022 09:00 ET | Source: Optimi Health Corp.

Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of Psilocybin, MDMA

VANCOUVER, British Columbia, June 28, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
March 01, 2022 09:00 ET | Source: Optimi Health Corp.

Optimi Health Upgrades Trading to the OTCQX Best Market

VANCOUVER, British Columbia, March 01, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
February 22, 2022 10:34 ET | Source: Optimi Health Corp.

UPDATE - Optimi Health Launches E-Commerce Platform Featuring All-Natural Functional Mushroom Supplements

VANCOUVER, British Columbia., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
February 22, 2022 09:00 ET | Source: Optimi Health Corp.

Optimi Health Launches E-Commerce Platform Featuring All-Natural Functional Mushroom Supplements

VANCOUVER, British Columbia., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
February 16, 2022 09:00 ET | Source: Optimi Health Corp.

Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program

VANCOUVER, British Columbia, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
February 07, 2022 09:00 ET | Source: Optimi Health Corp.

Optimi Health Dealer’s License Granted by Health Canada

VANCOUVER, British Columbia, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
January 18, 2022 09:00 ET | Source: Optimi Health Corp.

Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations for Provisional Patent

VANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
January 05, 2022 16:17 ET | Source: Optimi Health Corp.

Optimi Health Provides Dealer License Update and Comments on Health Canada’s Amendments to the Special Access Program (SAP)

VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
December 21, 2021 09:00 ET | Source: Optimi Health Corp.

Optimi Health Receives Dealers License Inspection and Introduces Quality Assurance Department

VANCOUVER, British Columbia, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
December 07, 2021 09:00 ET | Source: Optimi Health Corp.

Optimi Health Requests Final Inspection for Dealer’s License

VANCOUVER, British Columbia, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...